AstraZeneca Entered into a Two-Year Collaboration with Thorne HealthTech for Disease Discovery System to Advance Novel Product Development


The collaboration focuses on Thorne’s disease discovery platform into AZ for further analysis, gaining insight for additional uses of AZ molecules & will identify novel and biologically plausible drug targets
The collaboration will provide innovative AI-driven technologies for drug discovery & will identify novel and biologically plausible drug targets. Thorne’s cloud-based AI illness discovery engine combines evidence from biology & chemistry to produce compound discoveries for new product development in the pharmaceutical & nutrition industries
The system uses a multi-omic platform & Thorne’s AI model which have been validated by numerous independent clinical studies in peer-reviewed publications

Ref: PR Newswire | Image: AstraZeneca